Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.39 |
| ▸ | PRKCA | P17252 | 3/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | FBP1 | P09467 | 1/20 | 0.36 |
| ▸ | TLR4 | O00206 | 1/20 | 0.36 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.35 |
| ▸ | PRKCG | P05129 | 1/20 | 0.35 |
| ▸ | PRKCB | P05771 | 1/20 | 0.35 |
| ▸ | PRKCH | P24723 | 1/20 | 0.35 |
| ▸ | PRKCI | P41743 | 1/20 | 0.35 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.35 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.35 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.35 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.35 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.35 |
| ▸ | LDHA | P00338 | 1/20 | 0.34 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2856288 | 1.00 | SLC2A1 (0.39) | SLC2A1PRKCACYP19A1PTGS1PTGS2 | |
| SCHEMBL2856299 | 0.93 | HCAR2 (0.42) | SLC2A1PRKCACYP19A1PTGS1PTGS2 | |
| SCHEMBL2856290 | 0.93 | HCAR2 (0.42) | SLC2A1PRKCACYP19A1PTGS1PTGS2 | |
| SCHEMBL2865963 | 0.92 | HCAR2 (0.41) | SLC2A1PRKCACYP19A1PTGS1PTGS2 | |
| SCHEMBL24621714 | 0.86 | SLC2A1 (0.38) | SLC2A1PRKCACYP19A1PTGS1PTGS2 | |
| SCHEMBL13214827 | 0.86 | SLC2A1 (0.38) | SLC2A1PRKCACYP19A1PTGS1PTGS2 | |
| SCHEMBL18306402 | 0.86 | SLC2A1 (0.38) | SLC2A1PRKCACYP19A1PTGS1PTGS2 | |
| SCHEMBL10233847 | 0.86 | SLC2A1 (0.38) | SLC2A1PRKCACYP19A1PTGS1PTGS2 | |
| SCHEMBL263214 | 0.86 | SLC2A1 (0.38) | SLC2A1PRKCACYP19A1PTGS1PTGS2 | |
| SCHEMBL24629824 | 0.86 | SLC2A1 (0.38) | SLC2A1PRKCACYP19A1PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100144651-A1 | NOVEL GLUCOPYRANOSE ESTERS AND GLUCOFURANOSE ESTERS OF ALKYL- FUMARATES AND THEIR PHARMACEUTICAL USE | ADITECH PHARMA AB (SE) | 2010-06-10 | — | — | US | disclosed |
| EP-2186819-A1 | Novel glucopyranose esters and glucofuranose esters of alkyl- fumarates and their pharmaceutical use | Aditech Pharma AG (CH) | 2010-05-19 | — | — | EP | disclosed |
| EP-1915387-B1 | NOVEL GLUCOPYRANOSE ESTERS AND GLUCOFURANOSE ESTERS OF ALKYL- FUMARATES AND THEIR PHARMACEUTICAL USE | ADITECH PHARMA AG (CH) | 2010-01-20 | — | — | EP | disclosed |
| EP-1915387-A1 | NOVEL GLUCOPYRANOSE ESTERS AND GLUCOFURANOSE ESTERS OF ALKYL- FUMARATES AND THEIR PHARMACEUTICAL USE | Aditech Pharma AB (SE) | 2008-04-30 | — | — | EP | disclosed |
| WO-2007006308-A1 | NOVEL GLUCOPYRANOSE ESTERS AND GLUCOFURANOSE ESTERS OF ALKYL- FU MARATES AND THEIR PHARMACEUTICAL USE | ADITECH PHARMA AB (SE) | 2007-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100144651-A1 | NOVEL GLUCOPYRANOSE ESTERS AND GLUCOFURANOSE ESTERS OF ALKYL- FUMARATES AND THEIR PHARMACEUTICAL USE | UGGT1, GALE, UGCG | SLC2A1 31/4885PRKCA 3072/4885CYP19A1 2355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.